Sign inGet started

Chesworth Richard

Insider CIK 1821188 · KYMR Chief Scientific Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
KYMR Kymera Therapeutics, Inc. M Exercise deriv2021-08-272021-08-2733,779— $0263,340SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2021-08-272021-08-2733,779$60.12 $2.03M0SEC↗
KYMR Kymera Therapeutics, Inc. M Exercise2021-08-272021-08-2733,779$20.00 $675.6K33,779SEC↗
KYMR Kymera Therapeutics, Inc. M Exercise deriv2021-08-172021-08-1954,000— $0297,119SEC↗
KYMR Kymera Therapeutics, Inc. M Exercise2021-08-172021-08-1954,000$20.00 $1.08M54,000SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2021-08-172021-08-198,809$49.90 $439.6K45,191SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2021-08-172021-08-1941,975$50.37 $2.11M3,216SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2021-08-172021-08-192,928$51.68 $151.3K288SEC↗
KYMR Kymera Therapeutics, Inc. S Sale2021-08-172021-08-19288$52.09 $15.0K0SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2021-03-012021-03-0360,000— $060,000SEC↗
KYMR Kymera Therapeutics, Inc. A Award deriv2020-08-202020-08-21351,119— $0351,119SEC↗